766 related articles for article (PubMed ID: 33769709)
1. Assessing the impact of COVID-19 on registered interventional clinical trials.
Hawila N; Berg A
Clin Transl Sci; 2021 May; 14(3):1147-1154. PubMed ID: 33769709
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis.
Mehta HB; Ehrhardt S; Moore TJ; Segal JB; Alexander GC
BMJ Open; 2020 Jun; 10(6):e039978. PubMed ID: 32518212
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic.
Gianola S; Jesus TS; Bargeri S; Castellini G
PLoS One; 2020; 15(10):e0240123. PubMed ID: 33022014
[TBL] [Abstract][Full Text] [Related]
4. Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry.
Xu P; Xing X; Yu K; Lv Z; Cui H; Shi Y; Chang T; Zhang D; Zhang Y; Wang K; Lu J; Huang Q; Li X; Cui Y; Shi L; Wang T; Niu J; Wang J
Emerg Microbes Infect; 2020 Dec; 9(1):1695-1701. PubMed ID: 32615862
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic clinical trials to combat COVID-19 pandemic in India: analysis from trial registry.
Batta A; Khirasaria R; Kapoor V; Varshney D
J Basic Clin Physiol Pharmacol; 2020 Dec; 32(3):267-278. PubMed ID: 33578506
[TBL] [Abstract][Full Text] [Related]
6. Conducting dermatology clinical trials during the COVID-19 pandemic.
Sheriff T; Dickenson-Panas H; Murrell DF
Clin Dermatol; 2021; 39(1):104-106. PubMed ID: 33972036
[TBL] [Abstract][Full Text] [Related]
7. Characteristics analysis for clinical study design relating to COVID-19 based on the database of ClinicalTrials.gov.
Wu H; Dai R; He P; Liang J; Li Q; Yang J; Lu H; Guo Q; Mao W; Ji C
Int J Infect Dis; 2022 Mar; 116():210-215. PubMed ID: 35017106
[TBL] [Abstract][Full Text] [Related]
8. Dramatic drop in new cancer drug trials during the COVID-19 pandemic.
Wilkinson E
Lancet Oncol; 2021 Mar; 22(3):305. PubMed ID: 33549163
[No Abstract] [Full Text] [Related]
9. Early Impact of COVID-19 on the Conduct of Oncology Clinical Trials and Long-Term Opportunities for Transformation: Findings From an American Society of Clinical Oncology Survey.
Waterhouse DM; Harvey RD; Hurley P; Levit LA; Kim ES; Klepin HD; Mileham KF; Nowakowski G; Schenkel C; Davis C; Bruinooge SS; Schilsky RL
JCO Oncol Pract; 2020 Jul; 16(7):417-421. PubMed ID: 32396491
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of COVID-19 Studies Registered with the Clinical Trials Registry of India [CTRI] - A database Analysis.
Vl C; Cj G; Sr B; Nn D; Nj G; Um T
J Assoc Physicians India; 2021 Oct; 69(10):11-12. PubMed ID: 34781650
[TBL] [Abstract][Full Text] [Related]
11. The Impact of COVID-19 on Clinical Trial Execution at the Dana-Farber Cancer Institute.
Tolaney SM; Lydon CA; Li T; Dai J; Standring A; Legor KA; Caparrotta CM; Schenker MP; Glazer DI; Tayob N; DuBois SG; Meyerhardt JA; Taplin ME; Johnson BE
J Natl Cancer Inst; 2021 Nov; 113(11):1453-1459. PubMed ID: 32959883
[TBL] [Abstract][Full Text] [Related]
12. Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study.
DeVito NJ; Bacon S; Goldacre B
Lancet; 2020 Feb; 395(10221):361-369. PubMed ID: 31958402
[TBL] [Abstract][Full Text] [Related]
13. Clinical impact of molecular point-of-care testing for suspected COVID-19 in hospital (COV-19POC): a prospective, interventional, non-randomised, controlled study.
Brendish NJ; Poole S; Naidu VV; Mansbridge CT; Norton NJ; Wheeler H; Presland L; Kidd S; Cortes NJ; Borca F; Phan H; Babbage G; Visseaux B; Ewings S; Clark TW
Lancet Respir Med; 2020 Dec; 8(12):1192-1200. PubMed ID: 33038974
[TBL] [Abstract][Full Text] [Related]
14. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
[TBL] [Abstract][Full Text] [Related]
15. Clinical Trial Data Sharing for COVID-19-Related Research.
Dron L; Dillman A; Zoratti MJ; Haggstrom J; Mills EJ; Park JJH
J Med Internet Res; 2021 Mar; 23(3):e26718. PubMed ID: 33684053
[TBL] [Abstract][Full Text] [Related]
16. The Impact of COVID-19 on the Conduct of Clinical Trials for Medical Products in Korea.
Jeon J; Kim H; Yu KS
J Korean Med Sci; 2020 Sep; 35(36):e329. PubMed ID: 32924344
[TBL] [Abstract][Full Text] [Related]
17. Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel.
Marcus N; Frizinsky S; Hagin D; Ovadia A; Hanna S; Farkash M; Maoz-Segal R; Agmon-Levin N; Broides A; Nahum A; Rosenberg E; Kuperman AA; Dinur-Schejter Y; Berkun Y; Toker O; Goldberg S; Confino-Cohen R; Scheuerman O; Badarneh B; Epstein-Rigbi N; Etzioni A; Dalal I; Somech R
Front Immunol; 2020; 11():614086. PubMed ID: 33519822
[TBL] [Abstract][Full Text] [Related]
18. Meeting the Demand for Unrelated Donors in the Midst of the COVID-19 Pandemic: Rapid Adaptations by the National Marrow Donor Program and Its Network Partners Ensured a Safe Supply of Donor Products.
Auletta JJ; Novakovich JL; Stritesky GL; Newman J; Fridy-Chesser ST; Hailperin K; Devine SM
Transplant Cell Ther; 2021 Feb; 27(2):133-141. PubMed ID: 33830022
[TBL] [Abstract][Full Text] [Related]
19. Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.
Post LA; Benishay ET; Moss CB; Murphy RL; Achenbach CJ; Ison MG; Resnick D; Singh LN; White J; Chaudhury AS; Boctor MJ; Welch SB; Oehmke JF
J Med Internet Res; 2021 Feb; 23(2):e25799. PubMed ID: 33475513
[TBL] [Abstract][Full Text] [Related]
20. It is unprecedented: trial management during the COVID-19 pandemic and beyond.
Mitchell EJ; Ahmed K; Breeman S; Cotton S; Constable L; Ferry G; Goodman K; Hickey H; Meakin G; Mironov K; Quann N; Wakefield N; McDonald A
Trials; 2020 Sep; 21(1):784. PubMed ID: 32917258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
